Advanced Targeting Systems

Advanced Targeting Systems (ATS) is a California-based biotechnology company specializing in providing high-quality targeting reagents for scientific research and pharmaceutical development. With a focus on neuroscience research, ATS offers a wide range of products including targeted toxins, antibodies, and custom services to aid scientists in studying system functions, cell functionality, diseases, and disorders.

ATS is renowned for pioneering the use of targeted conjugates in Molecular Surgery, offering lesioning agents for various neuronal types and macrophages, as well as a pan-neuronal agent. The company also provides secondary conjugates for converting users' own targeting agents into cytotoxic tools and screening antibodies for internalization. ATS's Saporin technology platform, developed and refined by Dr. Douglas Lappi and Dr. Ronald Wiley, has been commercialized and made accessible to scientists worldwide, thanks to the business expertise and international sales marketing efforts of Denise Higgins.

Generated from the website